Rakel López de Maturana Garmendia-rekin lankidetzan egindako argitalpenak (4)

2010

  1. Mecanismos implicados en la mejora cognitiva inducida por Rosiglitazona en un modelo animal de enfermedad de Alzheimer: XXXI Congreso Nacional de la SEF: póster premiado

    Actualidad en farmacología y terapéutica, Vol. 8, Núm. 1, pp. 71-74

  2. Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: Mechanisms involving a reduced amyloid and tau pathology

    Neuropsychopharmacology, Vol. 35, Núm. 7, pp. 1593-1604

2009

  1. Early changes in hippocampal eph receptors precede the onset of memory decline in mouse models of alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 17, Núm. 4, pp. 773-786

  2. Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels

    Neurobiology of Disease, Vol. 33, Núm. 3, pp. 369-378